In this document we provide a detailed account of (among others):
- Clinical activities in the past year
- Antimicrobial use/expenditures within the MUHC
- Priorities for 2021-2022
See in "Resources" section!
top of page
Search
Recent Posts
See AllINESSS approved the TDM of Linezolid in May 2024 It is now available in the MUHC (via HSJ labs) The ASP committee is happy to publish a...
The ASP chairs are happy to publish the MUHC ASP annual report 2022-2023, now available in the Resources section of the MUHC ASP website....
The ASP committee is happy to give you an early Christmas gift! We published the guidelines on management and treatment of Staphylococcus...
bottom of page
Kommentare